EARLY CONFIRMED TOP INDUSTRY Speakers

 

Kate Adcock, Director of Research and Innovation, The Muscular Dystrophy U.K.

Kate Adcock | Director of Research and Innovation | The Muscular Dystrophy U.K. » speaking at PPMA 2020

Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency

Jeonghoon Ahn | Director | National Evidence-based Healthcare Collaborating Agency » speaking at PPMA 2020

Tanya Aiden, Global Products Lead, BIOCAD

Tanya Aiden | Global Products Lead | BIOCAD » speaking at PPMA 2020

Amin Alamiri, Asst. Undersecretary of Health Policy & License, Ministry Of Health

Amin Alamiri | Asst. Undersecretary of Health Policy & License | Ministry Of Health » speaking at PPMA 2020

John Alter, Vice President Pricing And Market Access, Pfizer

John Alter | Vice President Pricing And Market Access | Pfizer » speaking at PPMA 2020

Mauricio Alvarez Reyes, Market Access Expert, Independent

Mauricio Alvarez Reyes | Market Access Expert | Independent » speaking at PPMA 2020

Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions

Ines Alves, President, ANDO Portugal

Ines Alves | President | ANDO Portugal » speaking at PPMA 2020

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo | R&D Rare Diseases Unit Head | Chiesi Farmaceutici SpA » speaking at PPMA 2020

Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI

Francis Arickx | Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy | National Institute for Health and Disability Insurance RIZIV-INAMI » speaking at PPMA 2020

Ramesh Arjunji, Senior Director Heor And Rwe, AveXis

Ramesh Arjunji | Senior Director Heor And Rwe | AveXis » speaking at PPMA 2020

Nadeem Ashraf, Medical Advisor - Diabetes, N/A

Kagan Atikeler, Pharmacist, Turkish Medicines and Medical Devices Agency

Kagan Atikeler | Pharmacist | Turkish Medicines and Medical Devices Agency » speaking at PPMA 2020

Dorthe Bartels, Strategic Adviser, Amgros

Dorthe Bartels | Strategic Adviser | Amgros » speaking at PPMA 2020

Alex Bastian, Vice President, Value & Market Access, Galapagos NV

Alex Bastian | Vice President, Value & Market Access | Galapagos NV » speaking at PPMA 2020

Antje Behring, Acting Head, Federal Joint Committee

Antje Behring | Acting Head | Federal Joint Committee » speaking at PPMA 2020

Inge Bliestle, Chief Operating Officer, TolerogenixX

Inge Bliestle | Chief Operating Officer | TolerogenixX » speaking at PPMA 2020

Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement

Nadia Bodkin | Rare Disease Advocacy Professional | Rare Advocacy Movement » speaking at PPMA 2020

Axel Boehnke, Director Market Access Eu North, PTC Therapeutics

Axel Boehnke | Director Market Access Eu North | PTC Therapeutics » speaking at PPMA 2020

Luc Boileau, Chairman And Chief Executive Officer, Inesss

Luc Boileau | Chairman And Chief Executive Officer | Inesss » speaking at PPMA 2020

Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh

Hassan Bruneo | Associate Director | Alnylam Switzerland Gmbh » speaking at PPMA 2020

Anna Bucsics, Project Advisor, MoCA - Mechanism of Coordinated Access to Orphan M

Anna Bucsics | Project Advisor | MoCA - Mechanism of Coordinated Access to Orphan M » speaking at PPMA 2020

Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.

Rob Burley | Director Of Campaigns, Care And Support | The Muscular Dystrophy U.K. » speaking at PPMA 2020

Nicki Catterick, Senior Director, Global Market Access And Pricing, Merck Group

Nicki Catterick | Senior Director, Global Market Access And Pricing | Merck Group » speaking at PPMA 2020

David Catterick, Health Economics Senior Manager, Amgen

David Catterick | Health Economics Senior Manager | Amgen » speaking at PPMA 2020

Sandro Cesaro-Tadic, Head Pricing I8 & Product Pricing Strategies, Roche

Sandro Cesaro-Tadic | Head Pricing I8 & Product Pricing Strategies | Roche » speaking at PPMA 2020

Anjan Chatterjee, Global Head Of Real World Evidence, Boehringer Ingelheim Pharma GmbH & Co. KG

Anjan Chatterjee | Global Head Of Real World Evidence | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at PPMA 2020

Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline

Deven Chauhan | Senior Director, Value Evidence Leader | GlaxoSmithKline » speaking at PPMA 2020

Americo Cicchetti, Director, Universita Cattolica Del Sacro Cuore

Americo Cicchetti | Director | Universita Cattolica Del Sacro Cuore » speaking at PPMA 2020

Ali Ciger, Commercial Director, Pain, Pfizer

Ali Ciger | Commercial Director, Pain | Pfizer » speaking at PPMA 2020

Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)

Francis Crawley | Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer) | Good Clinical Practice Alliance (GCPA) » speaking at PPMA 2020

Omar Dabbous, Vice President, Health Economics And Outcomes Research, AveXis

Omar Dabbous | Vice President, Health Economics And Outcomes Research | AveXis » speaking at PPMA 2020

Charles De Cidrac, Director Of Health Insurance, AXA

Charles De Cidrac | Director Of Health Insurance | AXA » speaking at PPMA 2020

Carla Deakin, Programme Director - Commercial And Managed Access, NICE

Carla Deakin | Programme Director - Commercial And Managed Access | NICE » speaking at PPMA 2020

Olga Diachenko, Market Access Manager Europe, Accord Healthcare

Olga Diachenko | Market Access Manager Europe | Accord Healthcare » speaking at PPMA 2020

Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD

Valentin Dodonov | Deputy General Head Of Market Access | BIOCAD » speaking at PPMA 2020

Mark Duman, Nw Service Champion, Diabetes U.K.

Mark Duman | Nw Service Champion | Diabetes U.K. » speaking at PPMA 2020

Rudy Dupree, Senior Project Manager, Eunethta Wp4, EUnetHTA

Rudy Dupree | Senior Project Manager, Eunethta Wp4 | EUnetHTA » speaking at PPMA 2020

Jenny Ebert, National Account Director, Genzyme Sanofi Corp

Jenny Ebert | National Account Director | Genzyme Sanofi Corp » speaking at PPMA 2020

Gottfried Endel, Ebm, Hta Team Leader, H.V.B.

Gottfried Endel | Ebm, Hta Team Leader | H.V.B. » speaking at PPMA 2020

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at PPMA 2020

Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi

Valerie Faillat | Head Of Sanofi Espoir Foundation | Sanofi » speaking at PPMA 2020

Rute Fernandes, Head Of Rare Diseases Of Europe And Canada, Takeda

Rute Fernandes | Head Of Rare Diseases Of Europe And Canada | Takeda » speaking at PPMA 2020

Girisha Fernando, Independent, Independant

Girisha Fernando | Independent | Independant » speaking at PPMA 2020

Martina Flammer, Senior Vice President, Head Of Corporate Customer Value, Boehringer-Ingelheim

Steven Flostrand, Senior Director Of Pricing And Market Access, Celgene

Steven Flostrand | Senior Director Of Pricing And Market Access | Celgene » speaking at PPMA 2020

Douglas Foerster, Head Market Access Europe And Row, Santhera

Douglas Foerster | Head Market Access Europe And Row | Santhera » speaking at PPMA 2020

Kamilla Gaitova, Head of HTA Department, Republican Center for Health Development, Kazakhstan

Kamilla Gaitova | Head of HTA Department | Republican Center for Health Development, Kazakhstan » speaking at PPMA 2020

Benjamin Gannon, Vice President International Access, Policy and Advocacy, Myriad genetics

Benjamin Gannon | Vice President International Access, Policy and Advocacy | Myriad genetics » speaking at PPMA 2020

Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer

Oliver Gassner | Head Digital Health Intelligence | Emea | Bayer » speaking at PPMA 2020

Marcus Gaurdian, Chief Operating Officer, EUnetHTA

Marcus Gaurdian | Chief Operating Officer | EUnetHTA » speaking at PPMA 2020

Katrien Van Geyt, Head Of Market Access, Belgium And Luxembourg, Takeda

Katrien Van Geyt | Head Of Market Access, Belgium And Luxembourg | Takeda » speaking at PPMA 2020

Fabrizio Gianfrate, Professor Of Health Economics, Market Access Advisor, Universities of Rome and Ferrara

Fabrizio Gianfrate | Professor Of Health Economics, Market Access Advisor | Universities of Rome and Ferrara » speaking at PPMA 2020

Ivan Glushkov, External Affairs Department Director, STADA CIS

Ivan Glushkov | External Affairs Department Director | STADA CIS » speaking at PPMA 2020

Josie Godfrey, Director, JG Zebra Consulting

Josie Godfrey | Director | JG Zebra Consulting » speaking at PPMA 2020

Wim Goettsch, Special Hta-Advisor, Zorginstituut

Wim Goettsch | Special Hta-Advisor | Zorginstituut » speaking at PPMA 2020

Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical

Clare Hague | Therapy Area Market Access Lead, Hematology | Janssen Pharmaceutical » speaking at PPMA 2020

John P Hakanson, Global Head of Strategic Pricing, CSL Behring

John P Hakanson | Global Head of Strategic Pricing | CSL Behring » speaking at PPMA 2020

Stephen Hall, Knowledge Exchange Associate, NIHR Innovation Observatory, Newcastle University

Stephen Hall | Knowledge Exchange Associate | NIHR Innovation Observatory, Newcastle University » speaking at PPMA 2020

Adam Heathfield, Senior Director Of Global Health And Value Innovation Centre, Pfizer Ltd

Adam Heathfield | Senior Director Of Global Health And Value Innovation Centre | Pfizer Ltd » speaking at PPMA 2020

Ramon Hernandez Vecino, Head of Real World Evidence Data & Analytics Engagement Lead R&D, Sanofi

Ramon Hernandez Vecino | Head of Real World Evidence Data & Analytics Engagement Lead R&D | Sanofi » speaking at PPMA 2020

Stefan Holmstrom, Head, Hta Strategy And Pro Excellence, Astellas Pharma

Stefan Holmstrom | Head, Hta Strategy And Pro Excellence | Astellas Pharma » speaking at PPMA 2020

Birgit Holz, Global Head Of Contracting Innovation, Sanofi

Birgit Holz | Global Head Of Contracting Innovation | Sanofi » speaking at PPMA 2020

Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb

Nigel Hughes, Scientific Director, Rmeds Quantitative Sciences,, Janssen

Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma

Kankendria Ingram, Independent, Independent

Kankendria Ingram | Independent | Independent » speaking at PPMA 2020

Dawn Torrence Ireland, President And Founder, C.H.E.R.U.B.S.

Dawn Torrence Ireland | President And Founder | C.H.E.R.U.B.S. » speaking at PPMA 2020

Daniel Jackson, Global Head Of Market Access, Solutions And Strategy, UCB

Daniel Jackson | Global Head Of Market Access, Solutions And Strategy | UCB » speaking at PPMA 2020

Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen

Ulrike Jacobi | Head Of External Affairs And Market Access | Amgen » speaking at PPMA 2020

David Jakouloff, Global Head Of Market Access, Dmd, PTC Therapeutics

David Jakouloff | Global Head Of Market Access, Dmd | PTC Therapeutics » speaking at PPMA 2020

Saira Jan, Director Of Pharmacy Strategy And Clinical Integration, Blue Cross Blue Shield of New Jersey

Saira Jan | Director Of Pharmacy Strategy And Clinical Integration | Blue Cross Blue Shield of New Jersey » speaking at PPMA 2020

Rasmus Jensen, Global Head Of Market Access, Camurus

Rasmus Jensen | Global Head Of Market Access | Camurus » speaking at PPMA 2020

Wendy Jory, Head Of Global Pricing Centre Of Excellence, Glaxosmithkline

Wendy Jory | Head Of Global Pricing Centre Of Excellence | Glaxosmithkline » speaking at PPMA 2020

Navin Joshi, Global Head Of Pricing, Classic And Established Products. Global Pharma, Head Of Pricing & Access Capabilities, Emerging Markets, Glaxosmithkline

Navin Joshi | Global Head Of Pricing, Classic And Established Products. Global Pharma, Head Of Pricing & Access Capabilities, Emerging Markets | Glaxosmithkline » speaking at PPMA 2020

Marcela Junqueira, Head Of Strategic Affairs And Health Economics, Janssen Pharmaceutical

Marcela Junqueira | Head Of Strategic Affairs And Health Economics | Janssen Pharmaceutical » speaking at PPMA 2020

Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical

Madhusudan Kabra | Director, Evidence Generation | Otsuka Pharmaceutical » speaking at PPMA 2020

Gomathi Kaliappan, Global Market Access (Health Systems Strategy, Value Recognition), Roche

Gomathi Kaliappan | Global Market Access (Health Systems Strategy, Value Recognition) | Roche » speaking at PPMA 2020

Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator Applications

Lisette Kaskens | Senior Global Market Access Manager | Advanced Accelerator Applications » speaking at PPMA 2020

Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis

Jolanda Koenders | Head Of Pricing And Market Access Pharma | Novartis » speaking at PPMA 2020

Shanthy Krishnaraja, Senior Director, Market Access And Strategy, Seqirus

Shanthy Krishnaraja | Senior Director, Market Access And Strategy | Seqirus » speaking at PPMA 2020

Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG

Irina Kurashkina, Advisor, External Affairs Department, S.T.A.D.A.

Irina Kurashkina | Advisor, External Affairs Department | S.T.A.D.A. » speaking at PPMA 2020

Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems

Marie-Liesse Le Corfec | Global Portfolio Marketing Head, Ps | B.D. Pharmaceuticals Systems » speaking at PPMA 2020

Jost Leemhuis, Head Of Safety Science, Roche

Jost Leemhuis | Head Of Safety Science | Roche » speaking at PPMA 2020

Giovanny Leon, Pricing And Market Access Director For Latin America And Canada, Novartis AG

Giovanny Leon | Pricing And Market Access Director For Latin America And Canada | Novartis AG » speaking at PPMA 2020

Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca

Sandy Leonard | Vice President Of Medical Evidence And Observational Research | AstraZeneca » speaking at PPMA 2020

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at PPMA 2020

Gavin Lewis, Vice President Of Value, Access And Policy, Amgen

Gavin Lewis | Vice President Of Value, Access And Policy | Amgen » speaking at PPMA 2020

Edmund Lim, Co-Founder, We CARE Journey

Edmund Lim | Co-Founder | We CARE Journey » speaking at PPMA 2020

Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark

Sune Lindgaard | Chief Of Business Intelligence | Amgros, Denmark » speaking at PPMA 2020

Catarina Lopes Pereira, Market Access Manager, Medicines for Europe

Catarina Lopes Pereira | Market Access Manager | Medicines for Europe » speaking at PPMA 2020

Kevin Loth, Vice President, Corporate Affairs and Policy, Worldwide Markets, Celgene

Kevin Loth | Vice President, Corporate Affairs and Policy, Worldwide Markets | Celgene » speaking at PPMA 2020

Elena Lungu, Manager Of Policy Development, Government of Canada (Canada)

Elena Lungu | Manager Of Policy Development | Government of Canada (Canada) » speaking at PPMA 2020

Mark Macgregor, Co-Vice Chair, Scottish Medicines Consortium, Nhs Scotland

Mark Macgregor | Co-Vice Chair, Scottish Medicines Consortium | Nhs Scotland » speaking at PPMA 2020

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen | Medical Director | Norwegian Medicines Agency, Norway » speaking at PPMA 2020

Joerg Mahlich, Head Of Health, Janssen Pharmaceutical K.K.

Andrea Mantovani, Former Head Of Value, Access And Policy For Biopharma Companies, Independent

Andrea Mantovani | Former Head Of Value, Access And Policy For Biopharma Companies | Independent » speaking at PPMA 2020

Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita

Marco Marchetti | Director Of The National Center For Health Technology Assessment | Istituto Superiore di Sanita » speaking at PPMA 2020

Anne Marciniak, Head Of Market Access, Europe, Aimmune

Anne Marciniak | Head Of Market Access, Europe | Aimmune » speaking at PPMA 2020

Cristina Martin-Rinconada, Head Of Value And Access For International Partners Markets (Mena And Ceer Regions), Biogen

Cristina Martin-Rinconada | Head Of Value And Access For International Partners Markets (Mena And Ceer Regions) | Biogen » speaking at PPMA 2020

Kevin Mayo, Global Head Of Market Access And New Products, PTC Therapeutics

Kevin Mayo | Global Head Of Market Access And New Products | PTC Therapeutics » speaking at PPMA 2020

Vipul Modi, Head Of Transformation For Innovation, Digital And Life Sciences, Oxford Academic Health Science Network

Vipul Modi | Head Of Transformation For Innovation, Digital And Life Sciences | Oxford Academic Health Science Network » speaking at PPMA 2020

Patrick Mollon, Heor Consultant, Gmap, Ipsen Pharma

Patrick Mollon | Heor Consultant, Gmap | Ipsen Pharma » speaking at PPMA 2020

Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany

Thomas Mueller | Head Of Directorate General 1 'Drugs, Medical Devices, Biotechnology' | Federal Ministry of Health Germany » speaking at PPMA 2020

Michael Müller, Head Of Market Access, Western Europe, Sun Pharma

Michael Müller | Head Of Market Access, Western Europe | Sun Pharma » speaking at PPMA 2020

Peter Mulley, Director Global Market Access, ViiV Healthcare

Peter Mulley | Director Global Market Access | ViiV Healthcare » speaking at PPMA 2020

Diane Munch, VP, Global Pricing, Patient & Health Impact, Pfizer

Diane Munch | VP, Global Pricing, Patient & Health Impact | Pfizer » speaking at PPMA 2020

Nuriya Musina, Head Of Development, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R

Nuriya Musina | Head Of Development | Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R » speaking at PPMA 2020

Sue Naeyaert, Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars, Fresenius Kabi

Sue Naeyaert | Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars | Fresenius Kabi » speaking at PPMA 2020

Hanadi Nahas, Chairman And General Manager, Access Core

Hanadi Nahas | Chairman And General Manager | Access Core » speaking at PPMA 2020

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at PPMA 2020

Claudia Neuber, Head Of Global Pricing Implementation, AstraZeneca

Claudia Neuber | Head Of Global Pricing Implementation | AstraZeneca » speaking at PPMA 2020

Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical

Enkeleida Nikai | Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea) | Janssen Pharmaceutical » speaking at PPMA 2020

Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma

Waldemar Ockert | Director, Rwi Business Market Analytics | Astellas Pharma » speaking at PPMA 2020

Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh

Irina Odnoletkova | Vice President Health Technology Assessment | Apogenix Gmbh » speaking at PPMA 2020

Laura O'Hanlon, Associate Director, International Market Access/Reimbursement, Myriad genetics

Laura O'Hanlon | Associate Director, International Market Access/Reimbursement | Myriad genetics » speaking at PPMA 2020

Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma

Melvin Olson | Global Head Rwd Strategy And Innovation | Novartis Pharma » speaking at PPMA 2020

Vitaly Omelyanovskiy, General Director, Center Of Healthcare Quality Assessment And Control, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R

Vitaly Omelyanovskiy | General Director, Center Of Healthcare Quality Assessment And Control | Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R » speaking at PPMA 2020

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Nneka Onwudiwe | Founder And Chief Executive Officer | Pharmaceutical Economics Consultants of America (PECA) LLC » speaking at PPMA 2020

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski | Chief Operating Officer | Lancaster Cancer Centre » speaking at PPMA 2020

Mario Ouwens, Senior Statistical Science Director, Astra Zeneca

Mario Ouwens | Senior Statistical Science Director | Astra Zeneca » speaking at PPMA 2020

Arrigo Paciello, Scientific Advisor, AIFA

Arrigo Paciello | Scientific Advisor | AIFA » speaking at PPMA 2020

Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System

Melissa Paige | Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate | U.V.A. Health System » speaking at PPMA 2020

Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi

Ana Palma | Senior Director Global Hta And Patient Access Lead | Sobi » speaking at PPMA 2020

Elena Panitti, Global Rwe Capability Building Lead, Novartis

Elena Panitti | Global Rwe Capability Building Lead | Novartis » speaking at PPMA 2020

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Detlev Parow | Head Pharmaceutical Department | D.A.K. » speaking at PPMA 2020

Chris Pashos, Vice President Of Global Evidence Strategy, AbbVie

Chris Pashos | Vice President Of Global Evidence Strategy | AbbVie » speaking at PPMA 2020

Julien Patris, Associate Director of Market Access and Policy for Europe and Canada, Alnylam

Julien Patris | Associate Director of Market Access and Policy for Europe and Canada | Alnylam » speaking at PPMA 2020

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer-Ingelheim » speaking at PPMA 2020

Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company

Ed Pezalla | Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy | Aetna; a CVS Pharmacy Health Company » speaking at PPMA 2020

Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director And Director Of Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at PPMA 2020

Sagie Pillay, Chief Operating Officer, Wits Health Consortium

Sagie Pillay | Chief Operating Officer | Wits Health Consortium » speaking at PPMA 2020

Oresta Piniazhko, Director, HTA Department, Ministry of Health of Ukraine

Oresta Piniazhko | Director, HTA Department | Ministry of Health of Ukraine » speaking at PPMA 2020

Lara Pippo, Head Of Market Access, CSL Behring

Lara Pippo | Head Of Market Access | CSL Behring » speaking at PPMA 2020

Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics

Sarah Pitluck | Head, Global Pricing And Reimbursement | Spark Therapeutics » speaking at PPMA 2020

Adam Plich, Managing Director, Plich Advisory

Adam Plich | Managing Director | Plich Advisory » speaking at PPMA 2020

Angelina Irizari Policarpio, Head Of Us Heor Field Team And Us Quality, Boehringer Ingelheim

Angelina Irizari Policarpio | Head Of Us Heor Field Team And Us Quality | Boehringer Ingelheim » speaking at PPMA 2020

Robert Popovian, Vice President Of Government Relations, Pfizer

Robert Popovian | Vice President Of Government Relations | Pfizer » speaking at PPMA 2020

Diann Potestio, Vice President Market Access, Ascendis Pharma

Diann Potestio | Vice President Market Access | Ascendis Pharma » speaking at PPMA 2020

Martin Price, Vice President Of Health Economics, Market Access And Reimbursement, Johnson & Johnson

Martin Price | Vice President Of Health Economics, Market Access And Reimbursement | Johnson & Johnson » speaking at PPMA 2020

Rajakanth Raman, Executive Director, Rainbow Across Borders Limited

Rajakanth Raman | Executive Director | Rainbow Across Borders Limited » speaking at PPMA 2020

Andrew Richards, Head Of Global Market Access And Pricing, Ferring

Andrew Richards | Head Of Global Market Access And Pricing | Ferring » speaking at PPMA 2020

Kevin Rieger, Head Of Eu Affairs, BPI

Kevin Rieger | Head Of Eu Affairs | BPI » speaking at PPMA 2020

Juan Roman, Head Of Market Access And Pricing, Acceleron Pharmaceuticals, Inc.

Juan Roman | Head Of Market Access And Pricing | Acceleron Pharmaceuticals, Inc. » speaking at PPMA 2020

Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency

Giuseppe Rosano | Member Of The Cardiovascular Working Party | European Medicines Agency » speaking at PPMA 2020

Micah Rose, Senior Scientific Adviser, Health Economic Modelling, National Institute for Health and Care Excellence

Micah Rose | Senior Scientific Adviser, Health Economic Modelling | National Institute for Health and Care Excellence » speaking at PPMA 2020

Igor Rudychev, Head Of Us Digital, Data, And Innovations, AstraZeneca

Igor Rudychev | Head Of Us Digital, Data, And Innovations | AstraZeneca » speaking at PPMA 2020

Peter Rutherford, Global Medical Lead Of Orphan Renal Diseases, Vifor Pharma Group

Peter Rutherford | Global Medical Lead Of Orphan Renal Diseases | Vifor Pharma Group » speaking at PPMA 2020

Ryan Saadi, Vice President, Global Market Access, CSL Behring

Ryan Saadi | Vice President, Global Market Access | CSL Behring » speaking at PPMA 2020

Rasha Salama, Ministry Public Health Consultant And Advisor, Ministry Of Health

Rasha Salama | Ministry Public Health Consultant And Advisor | Ministry Of Health » speaking at PPMA 2020

Yves Samel, Market Access Strategy Leader And Global Pricing Manager, Bayer

Yves Samel | Market Access Strategy Leader And Global Pricing Manager | Bayer » speaking at PPMA 2020

Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access And Trade | Paratek Pharmaceuticals , Inc. » speaking at PPMA 2020

Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline

Gustavo Saraiva Dos Anjos | Global Market Access Director For Biologics | GlaxoSmithKline » speaking at PPMA 2020

Meriam Sbeity, Market Access Specialist, Access Core

Meriam Sbeity | Market Access Specialist | Access Core » speaking at PPMA 2020

Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda

Gundula Schneidewind | Head Ethics And Compliance, Europe And Canada | Takeda » speaking at PPMA 2020

Michael Schroter, Partner, Viopas Partners

Michael Schroter | Partner | Viopas Partners » speaking at PPMA 2020

Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands

Ad Schuurman | Senior Advisor International Affairs | National Health Care Institute (ZIN), the Netherlands » speaking at PPMA 2020

Nabil Seidov, Deputy Head Of Department For Health Policy And Planning Of Public Health And Reforms Centre, Ministry of Healthcare of Azerbaijan Republic

Nabil Seidov | Deputy Head Of Department For Health Policy And Planning Of Public Health And Reforms Centre | Ministry of Healthcare of Azerbaijan Republic » speaking at PPMA 2020

Ayman Semaan, Head Of Market Access, Algorithm

Ayman Semaan | Head Of Market Access | Algorithm » speaking at PPMA 2020

Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen

Simon Shohet | Senior Director, Global Market Access And Pricing | Ipsen » speaking at PPMA 2020

Rita Shorjian, Market Access Head - Near East And North West Africa, AbbVie

Rita Shorjian | Market Access Head - Near East And North West Africa | AbbVie » speaking at PPMA 2020

Dorinda Silva, Volunteer Patient Advocate, Portuguese Association for CDG and other Rare Metabolic Diseases

Dorinda Silva | Volunteer Patient Advocate | Portuguese Association for CDG and other Rare Metabolic Diseases » speaking at PPMA 2020

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Tamir Singer | Head Of Commercial Development, Specialised Commissioning | NHS England » speaking at PPMA 2020

Stefan Sladecek, Head Of Market Access Austria, Roche Diagnostics

Stefan Sladecek | Head Of Market Access Austria | Roche Diagnostics » speaking at PPMA 2020

Sebastian Soluch, Head of Market Access and Pricing, Europe, Stemline Therapeutics Inc

Sebastian Soluch | Head of Market Access and Pricing, Europe | Stemline Therapeutics Inc » speaking at PPMA 2020

Ulf Staginnus, Senior Vice President, Head Of Global Market Access And Pricing, Ipsen Pharma

Ulf Staginnus | Senior Vice President, Head Of Global Market Access And Pricing | Ipsen Pharma » speaking at PPMA 2020

Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm

Anastasiya Stepanova | State Authorities Manager | JSC Nizhpharm » speaking at PPMA 2020

Richard Stephens, Patient Advocate, Independant

Richard Stephens | Patient Advocate | Independant » speaking at PPMA 2020

Giovanni Tafuri, Eunethta, Senior Scientific Officer, National Health Care Institute (ZIN), the Netherlands

Giovanni Tafuri | Eunethta, Senior Scientific Officer | National Health Care Institute (ZIN), the Netherlands » speaking at PPMA 2020

Bertrand Tardivel, General Manager, Frehel GmbH

Bertrand Tardivel | General Manager | Frehel GmbH » speaking at PPMA 2020

Samuel Taylor, Emerging Markets Pricing Lead, Pfizer

Samuel Taylor | Emerging Markets Pricing Lead | Pfizer » speaking at PPMA 2020

Renske Ten Ham, Researcher, Utrecht University

Renske Ten Ham | Researcher | Utrecht University » speaking at PPMA 2020

Bharat Tewarie, Executive Vice President And Chief Marketing Officer, UCB

Bharat Tewarie | Executive Vice President And Chief Marketing Officer | UCB » speaking at PPMA 2020

David Thompson, Senior Vice President, Head Of Thought Leadership, Real World And Late Phase Research, Syneos Health

Gwilym Thompson, Director Worldwide Heor, BMS

Gwilym Thompson | Director Worldwide Heor | BMS » speaking at PPMA 2020

Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD

Daria Tolkacheva | Head Of Health Economics | JSC BIOCAD » speaking at PPMA 2020

Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany

Jorg Tomeczkowski | Head Of Market Access | Janssen Cilag Germany » speaking at PPMA 2020

Keiko Tone, Vice President Global Market Access, Shionogi Inc

Keiko Tone | Vice President Global Market Access | Shionogi Inc » speaking at PPMA 2020

Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health

Ariella Toren | Director Of Medicine And Medical Technologies, Hmos Department | Israel - Ministry Of Health » speaking at PPMA 2020

Sheela Upadhyaya, Associate Director Hst, National Institute for Health and Care Excellence

Sheela Upadhyaya | Associate Director Hst | National Institute for Health and Care Excellence » speaking at PPMA 2020

Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences

Bart Van Den Daele | Head of External Affairs – Director Market Access | Gilead Sciences » speaking at PPMA 2020

Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health

Evert Jan Van Lente, Director Of Eu Affairs, AOK Bundesverdand

Evert Jan Van Lente | Director Of Eu Affairs | AOK Bundesverdand » speaking at PPMA 2020

Christina Vandoros, Director, Macroeconomics And Health Policy - Emea, Janssen

Christina Vandoros | Director, Macroeconomics And Health Policy - Emea | Janssen » speaking at PPMA 2020

Stefan Vegter, Market Access Manager, Novartis

Stefan Vegter | Market Access Manager | Novartis » speaking at PPMA 2020

Kart Veliste, Chief Specialist At Department Of Medicines And Medical Devices, Haigekassa Estonia

Kart Veliste | Chief Specialist At Department Of Medicines And Medical Devices | Haigekassa Estonia » speaking at PPMA 2020

Jaume Vidal, Policy Advisor, Eu Projects, Health Action International

Jaume Vidal | Policy Advisor, Eu Projects | Health Action International » speaking at PPMA 2020

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck | Market Access Strategy Leader | Bayer Corp » speaking at PPMA 2020

David Watson, Director Pricing And Reimbursement, ABPI

David Watson | Director Pricing And Reimbursement | ABPI » speaking at PPMA 2020

Lindsay Weaver, Executive Director, Children Living With Inherited Metabolic Diseases

Lindsay Weaver | Executive Director | Children Living With Inherited Metabolic Diseases » speaking at PPMA 2020

Keith White, VP, Market Access and Pricing, Intercept Pharmaceuticals Inc

Keith White | VP, Market Access and Pricing | Intercept Pharmaceuticals Inc » speaking at PPMA 2020

Durhane Wong-Rieger, President And Chief Executive Officer, Canadian Organization For Rare Disorders

Durhane Wong-Rieger | President And Chief Executive Officer | Canadian Organization For Rare Disorders » speaking at PPMA 2020

Entela Xoxi, Former Aifa, Universita Cattolica Del Sacro Cuore

Entela Xoxi | Former Aifa | Universita Cattolica Del Sacro Cuore » speaking at PPMA 2020

Natasa Zibelnik, Global Head Of Market Access, E.U.S.A. Pharma

Natasa Zibelnik | Global Head Of Market Access | E.U.S.A. Pharma » speaking at PPMA 2020

Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals

Martine Zimmermann | Global Head Of Regulatory Affairs | Alexion Pharmaceuticals » speaking at PPMA 2020

Fabrizio Zucca, Director Patient Access Dach, Sobi

Fabrizio Zucca | Director Patient Access Dach | Sobi » speaking at PPMA 2020

 

 

Contact us

To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052

edmond.rama@terrapinn.com

To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com